Edition:
India

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

2.66USD
22 Nov 2017
Change (% chg)

$0.04 (+1.53%)
Prev Close
$2.62
Open
$2.66
Day's High
$2.66
Day's Low
$2.62
Volume
154
Avg. Vol
5,753
52-wk High
$5.35
52-wk Low
$2.62

Select another date:

Thu, Nov 16 2017

BRIEF-Tapimmune Q3 loss earnings per share $0.39‍​

* Tapimmune provides third quarter 2017 corporate and clinical update

BRIEF-TapImmune appoints Peter Hoang as president and CEO

* TapImmune appoints Peter Hoang as president and chief executive officer

BRIEF-Tapimmune files for‍​ resale of 4.4 mln shares of common stock held by selling stockholders

* Tapimmune Inc - Files for‍​ resale 4.4 million shares of common stock which are currently held by selling stockholders - SEC filing Source text: [http://bit.ly/2hjwILz] Further company coverage:

BRIEF-TapImmune reaches 50 pct patient enrollment benchmark in phase 2 study of novel t-cell vaccine targeting triple-negative breast cancer

* TapImmune reaches 50% patient enrollment benchmark in phase 2 study of novel t-cell vaccine targeting triple-negative breast cancer

BRIEF-TapImmune to raise $6.82 million in a private placement

* Tapimmune inc. Enters into definitive agreements to raise $6.82 million in a private placement from accredited investors and from the exercise of warrants by existing institutional investors

Select another date: